Pfizer Inc.’s proposed $160 billion merger with Allergan plc fizzled dramatically on Wednesday, after months of public anger and regulatory angst over the controversial tax inversion deal.
So why should Pfizer be thanking its lawyers?
The demise of a controversial tax inversion deal with Allergan may have frustrated Pfizer, but it doesn't leave the U.S. drug giant that much poorer.
April 06, 2016 at 08:27 PM
1 minute read
The original version of this story was published on The American Lawyer
Pfizer Inc.’s proposed $160 billion merger with Allergan plc fizzled dramatically on Wednesday, after months of public anger and regulatory angst over the controversial tax inversion deal.
So why should Pfizer be thanking its lawyers?
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS